What guidance did CCC Intelligent's management provide for the next earnings period?

What is CCC Intelligent's latest dividend and current dividend yield?

What is CCC Intelligent's gross profit margin?

What were the key takeaways from CCC Intelligent's earnings call?

What is the revenue and EPS growth rate for CCC Intelligent year over year?

What factors drove the changes in CCC Intelligent's revenue and profit?

What is the market's earnings forecast for CCC Intelligent next quarter?

What does CCC Intelligent do and what are its main business segments?

- **Record Financial Performance**: $1.057B revenue (12% YoY), $436M Adjusted EBITDA (41% margin), and $255M free cash flow in 2025. 
- **AI Growth Engine**: 10% of revenue from AI solutions, 70% YoY growth in emerging solutions, and 15,000 repair shops using AI tools. 
- **Strategic Acquisitions**: EvolutionIQ adds 9 top disability carriers and expands into workers' comp, with first cross-sell to existing CCC customer. 
- **Capital Return**: $1.1B returned to shareholders via buybacks, with $500M program activated in Q4. 
- **2026 Outlook**: 9% revenue growth to $1.15B and 42% EBITDA margin, driven by AI scale and subscription model resilience.

**【CEO Summary Section】**
- **Q4 2025 Financial Highlights**: Total revenue of $278 million (13% YoY growth), Adjusted EBITDA of $119 million (43% margin), and full-year revenue of $1.057 billion (12% YoY growth). 
- **AI and Emerging Solutions Growth**: Emerging solutions contributed 5% of Q4 revenue, growing 70% YoY, driven by AI-based APD, subrogation, and diagnostics. 
- **EvolutionIQ Integration**: Workers' comp and disability solutions added 9 of 15 top carriers, with cross-sell to existing CCC customers. 
- **Capital Allocation**: Completed $300M share buyback, authorized $500M additional repurchases, and maintained 2.7x net leverage. 
- **2026 Outlook**: Guided for $1.147B-$1.157B revenue (9% YoY growth) and $477M-$485M Adjusted EBITDA (42% margin). 

**【CFO Financial Commentary】**
- **Q4 2025 Financials**: GAAP net income $420M, Non-GAAP EPS $1.08 (vs. $1.02 consensus). Free cash flow $105M (12M trailing $255M). 
- **Cost Management**: Operating expenses flat YoY (excluding EvolutionIQ), stock-based comp 12% of revenue (down from 17% in 2024). 
- **Subscription Model Strength**: 85% of revenue from subscriptions, reducing claim volume sensitivity. 
- **Margin Expansion**: 200bps EBITDA margin expansion YoY, targeting 80% gross margin with AI scale. 

**【Q&A Key Highlights】**
- **AI Adoption**: 10% of revenue from AI solutions, 15,000 repair shops using AI tools, and 9% gross dollar retention. 
- **Customer Momentum**: 900,000 registered users processing $200B annually, 14/15 top OEMs as clients. 
- **Risk Mitigation**: Claim volume decline moderating (3% YoY ex-weather), 85% subscription contracts. 
- **Competitive Position**: Proprietary data ($2T historical), network of 35,000+ companies, and regulated industry expertise differentiate CCC. 
- **Share Buybacks**: $1.1B returned to shareholders since Q3 2024, with $500M program activated in Q4.

CCC Intelligent Solutions Holdings Inc(CCC)-20260225-2025 Q4 Earnings call transcript

- **Revenue & Profit Growth**: Q3 revenue up 12% YoY to $267M, EBITDA margin 41%. Full year guidance raised to $1.051-1.056B (12% YoY). 
- **AI Adoption Surge**: Top APD insurer increased AI claims from 15% to 40%; 1M+ AI estimates/month via Mobile JumpStart. 
- **Casualty Expansion**: 10% of revenue, 1/5 APD clients. Liberty Mutual transitions casualty business; EvolutionIQ's Medhub processes 6M docs/Q3. 
- **Financial Strength**: Free cash flow $79M (28% YoY), $280M share buybacks YTD. 2026 margin expansion resumes post-Q4 onetime costs.

**【CEO Summary Section】**
- Q3 2025 revenue: $267 million (12% YoY growth), Adjusted EBITDA: $110 million (41% margin). Key drivers: cross-sell/upsell (5pts), new logos (3pts), EvolutionIQ (4pts). 
- AI adoption momentum: top APD insurer increased claims with AI from 15% to 40%; Liberty Mutual transitions casualty business to CCC platform. 
- Casualty growth outpaces company (10% of revenue, 1/5 of APD clients). EvolutionIQ's Medhub processed 6M documents, 5.5M summaries. 
- Organizational investments: refining go-to-market strategy, adding strategic sales talent, separating CPO/CTO roles. 

**【CFO Financial Commentary】**
- Q3 2025: GAAP net income $420M, Non-GAAP EPS $1.08 (vs. $0.95 guidance). 
- Gross profit: $199M (75% margin, down 3pts YoY due to depreciation). Operating expenses: $106M (12% YoY incl. EvolutionIQ). 
- Free cash flow: $79M (28% YoY growth). Share buybacks: $280M YTD under $300M program. 
- Q4 2025 guidance: Revenue $272-277M (10-12% YoY), EBITDA $106-111M (40% margin). Full year: $1.051-1.056B (12% YoY). 

**【Q&A Highlights】**
- **AI monetization**: Client with 40% AI adoption sees ~50% incremental revenue from AI layer. 
- **EvolutionIQ**: Q3 contribution 4pts vs. 5pts target, timing delays in deployments. 
- **Growth strategy**: 8% core growth (excluding EvolutionIQ), 1pt headwind from claim volume decline. Casualty and emerging solutions drive long-term expansion. 
- **Margin outlook**: Stock comp as % of revenue to trend to low single digits by 2027. 2026 margin expansion resumes post-Q4 onetime costs.

CCC Intelligent Solutions Holdings Inc. (CCCS) Q3 2025 Earnings Call Transcript

- **Revenue & Profit Growth**: Q2 revenue up 12% YoY to $260.5M, EBITDA margin 42%. Full year guidance maintained at $1.046-1.056B. 
- **AI Adoption Surge**: Top 10 insurers expanding use of AI solutions (APD, subrogation), cutting claim cycle times by 50%. 
- **Operational Efficiency**: 99% gross retention, $2M one-time cost savings, 23% free cash flow margin. 
- **EvolutionIQ Impact**: 2025 EBITDA drag of ~3%, but strong pipeline and cross-sell opportunities. 
- **Risk Factor**: Claims volume decline (8% YoY) expected to persist, impacting transactional revenue.

**【CEO Summary Section】**
- Q2 2025 revenue: $260.5 million (12% YoY growth), exceeding guidance. Adjusted EBITDA: $108 million (42% margin). 
- Key themes: 
  1. AI adoption acceleration: Top 10 insurers expanding use of APD solutions (e.g., AI for total loss identification, supplement automation). 
  2. Operational efficiency & innovation balance: 99% GDR, 107% NDR, $2 million one-time cost benefit. 
  3. Interconnected network strength: 35,000+ network businesses, IX Cloud enabling event-based AI workflows. 
- Casualty growth: 10% of revenue, 1/5 customer base of APD. EvolutionIQ's Medhub integration driving cross-sell opportunities. 
- New Board member: Barak Eilam (former NICE CEO) to support AI/innovation strategy.

**【CFO Financial Commentary】**
- Revenue breakdown: 5% cross-sell/upsell, 3% new logos, 4% EvolutionIQ. Emerging solutions (e.g., Diagnostics, subrogation) contribute 4% growth. 
- Gross margin: 78% (flat YoY). Operating expenses: $108 million (13% YoY incl. EvolutionIQ). 
- Q3 2025 guidance: Revenue $263-266 million (10-12% YoY), EBITDA $104-107 million. Full year: $1.046-1.056 billion (11-12% YoY). 
- Free cash flow: $27 million Q2, $226 million trailing 12-months (23% margin). 
- Share buybacks: $172 million YTD under $300M program.

**【Q&A Highlights】**
- **Claims volume decline**: 8% YoY (1% growth headwind), expected to persist. 
- **EvolutionIQ delays**: 2025 revenue impact of ~$20 million due to implementation delays, but strong pipeline and cross-sell opportunities. 
- **AI adoption timeline**: Pilots to production takes ~2 years; top 10 insurers now rolling out solutions broadly. 
- **Competitive landscape**: Horizontal SaaS players lack CCC's vertical depth (e.g., photo AI, network scale). 
- **Casualty growth drivers**: Casualty claims inflation outpacing healthcare, driving demand for AI solutions.

CCC Intelligent Solutions Holdings Inc. (CCCS) Q2 2025 Earnings Call Transcript

- **Revenue Growth**: Q1 2025 revenue up 11% YoY to $252 million, driven by cross-sell, new logos, and EvolutionIQ.
- **Strategic Wins**: Major OEM contract and Caliber Collision renewal expand into diagnostics and Casualty solutions.
- **Emerging Solutions**: 2% growth from newer products, with MedHub launch targeting 5:1 ROI in Casualty.
- **Financial Health**: 77% gross margin, $44 million free cash flow, and $72 million share buybacks.
- **Risks**: 1% YoY headwind from claim volume decline, cautious outlook on sales cycles due to macro uncertainty.

**【CEO Summary Section】**
- Q1 2025 revenue reached $252 million, up 11% YoY, surpassing the $1 billion annualized run rate threshold. Adjusted EBITDA was $99 million, with a 39% margin.
- Key themes: navigating industry complexity, client commitment to CCC as a long-term innovation platform, and adoption of newer solutions.
- Claim volumes declined 9% YoY due to consumer economic sensitivity, but this is expected to normalize over time.
- Signed a major OEM contract and renewed a long-term deal with Caliber Collision, expanding into diagnostics and build sheets.
- Casualty business growth potential is highlighted, with 7 of the top 10 workers' compensation insurers already being CCC clients.
- Launched MedHub, an AI-powered medical synthesis tool, in Q3 2025, integrating EvolutionIQ's capabilities into Casualty solutions.

**【CFO Financial Commentary】**
- Q1 revenue growth of 10.7% YoY, with 4% from cross-sell/upsell, 3% from new logos, and 4% from EvolutionIQ.
- Emerging Solutions contributed 2% of growth, driven by diagnostics, build sheets, and subrogation.
- Gross profit margin was 77%, up from 76% QoQ, with operating expenses up 15% YoY due to EvolutionIQ integration.
- Free cash flow was $44 million, up 10% YoY, with $72 million in share buybacks under a $300 million program.
- Q2 2025 guidance: $255.5-257.5 million revenue (10-11% YoY growth), $99-101 million EBITDA.
- Full-year 2025 revenue expected at $1.046-1.056 billion (11% YoY growth), with EBITDA margin of 40%.
- Stock-based compensation as a % of revenue is 17% for 2025, front-loaded in Q1.

**【Q&A Highlights】**
- **Claims Volume**: Cyclical decline due to consumers raising deductibles and unfiled small claims. 25% of repair facilities now capture self-pay business, up from 11% three years ago.
- **MedHub Efficiency**: Early adopters report 20%+ efficiency gains and low-single-digit combined ratio improvements. Pricing will be subscription-based with ROI focus.
- **Macro Impact**: 1% YoY headwind from claim volume, but strong demand for ROI-driven solutions like Estimate-STP and subrogation.
- **Competitive Position**: 99% GDR reflects customer retention strength; 107% NDR shows cross-sell momentum. EvolutionIQ's 150+ NDR in disability business adds resilience.
- **Tariffs**: Minimal direct impact on CCC's subscription model, but providing data insights to clients on parts pricing volatility.


CCC Intelligent Solutions (CCCS)-6 May 25-2025 Q1 Earnings call transcript

- **Revenue Growth Momentum**: Q4 2024 revenue up 8% YoY, FY2024 total revenue up 9% YoY
- **AI-Driven Expansion**: AI solutions now live at 100+ insurers, 10,000+ repair shops
- **Strategic Acquisitions Paying Dividends**: EvolutionIQ to contribute $45M-$50M in 2025
- **Margin Expansion**: Core business margin to grow 75bps YoY, free cash flow margin up 200bps YoY
- **Emerging Solutions Breakthrough**: 30%+ growth rate, 25% reduction in parts returns for repair shops

**【CEO Opening Remarks】**
- Q4 2024 revenue: $246 million (8% YoY growth), FY2024 total revenue: $945 million (9% YoY growth). Adjusted EBITDA margin expanded to 42% (up 130bps YoY). 
- Key achievements: 
  - Onboarded 1,000+ new collision repair facilities
  - Expanded partner ecosystem to 200+ technology providers
  - AI solutions now live at 100+ insurers and 10,000+ repair shops
  - Acquired EvolutionIQ to enter disability & workers' comp markets
- 2025 focus: Accelerate adoption of intelligent experiences (AI-driven workflows) through new package offerings and change management support.

**【CFO Financial Review】**
- Q4 2024 metrics: 
  - GAAP net income: $420 million
  - Non-GAAP EPS: $1.08 (vs. $0.95 consensus)
  - Free cash flow: $106 million (Q4) / $231 million (TTM)
- 2025 guidance: 
  - Revenue: $1.055B-$1.065B (12% YoY growth)
  - Adjusted EBITDA: $417M-$427M (40% margin)
  - EvolutionIQ contribution: $45M-$50M
- Margin dynamics: 
  - Core business margin to expand 75bps YoY
  - EvolutionIQ EBITDA loss expected to moderate sequentially

**【Q&A Highlights】**
- **Organic Growth Drivers**: 
  - 7-10% base growth from core solutions
  - 1pt+ contribution from emerging solutions (e.g., diagnostics, build sheets)
  - 5pts+ from EvolutionIQ scaling
- **Emerging Solutions Adoption**: 
  - 3% of revenue, 30%+ growth rate
  - 25% reduction in parts returns for repair shops using build sheets
- **AI & Change Management**: 
  - Subrogation solution enables 40%+ same-day settlements
  - EvolutionIQ's medical document summarization tool being integrated into Casualty suite
- **Leverage Position**: 
  - Net debt: $1B (2x EBITDA post-EvolutionIQ acquisition)
  - Free cash flow margin: 24% (up 200bps YoY)

Actual	0.05	0.08	0.08	0.06	0.07	0.07	0.07	0.07	0.09	0.09	0.09	0.09	0.1	0.1	0.08	0.09	0.09	0.1
Forecast	0.0575	0.0588	0.0701	0.0701	0.0727	0.0697	0.0689	0.0672	0.0786	0.0846	0.0847	0.0822	0.0925	0.0961	0.0818	0.0834	0.0896	0.0906
Surprise	-13.04%	+36.05%	+14.12%	-14.41%	-3.71%	+0.43%	+1.60%	+4.17%	+14.50%	+6.38%	+6.26%	+9.49%	+8.11%	+4.06%	-2.20%	+7.91%	+0.45%	+10.38%

CCC

CCC fundamentals

CCC Q4 2025 Earnings

Earnings Call

You can ask Aime

CCC

CCC fundamentals

CCC Q4 2025 Earnings

Earnings Call

CCC Earnings Call Summary for Q4/20255:00 PM on Feb 24, 2026

CCC Earnings Call Summary for Q3/20258:00 AM on Oct 30, 2025

CCC Earnings Call Summary for Q2/20255:00 PM on Jul 31, 2025

CCC Earnings Call Summary for Q1/20258:00 AM on May 6, 2025

CCC Earnings Call Summary for Q4/20245:00 PM on Feb 25, 2025

You can ask Aime